Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

Autor:	Locke, F. L.1 frederick.locke@moffitt.org, Miklos, D. B.2, Jacobson, C. A.3, Perales, M.-A.4, Kersten, M.-J.5, Oluwole, O. O.6, Ghobadi, A.7, Rapoport, A. P.8, McGuirk, J·9, Pagel, J. M.10, Muñoz, J.11, Farooq, U.12, van Meerten, T.13, Reagan, P. M.14, Sureda, A.15, Flinn, I. W.16, Vandenberghe, P.17, Song, K. W.18, Dickinson, M.19, Minnema, M. C.20
Zdroj:	New England Journal of Medicine. 2/17/2022, Vol. 386 Issue 7, p640-654. 15p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu